<DOC>
	<DOCNO>NCT00231634</DOCNO>
	<brief_summary>The purpose study compare effectiveness safety topiramate placebo treatment obesity Type 2 diabetes mellitus patient fail sulfonylurea therapy .</brief_summary>
	<brief_title>A Study Efficacy Safety Topiramate Obese , Type 2 Diabetic Patients Inadequately Controlled Sulfonylurea Therapy</brief_title>
	<detailed_description>Topiramate medication treatment seizure , approve treatment obesity . This randomized , double-blind , placebo control study evaluate effectiveness safety topiramate Type 2 diabetic patient obesity fail treatment sulfonylurea . After 4-week enrollment phase 8-week titration phase , patient receive either topiramate ( 96 , 192 , 256 mg twice daily ) placebo 44 week , follow 6-week follow-up phase . Assessments effectiveness include body weight , hemoglobin type A1c [ HbA1c ] ( measurement average blood sugar level several month ) , Body Mass Index ( BMI ) , fast plasma glucose ( FPG ) level , fast lipid profile , fast insulin , uric acid level , blood pressure , health relate quality life ( HRQOL ) measure . Safety evaluation , include incidence severity adverse event , hypoglycemic episode , clinical laboratory result liver enzymes , vital sign , perform throughout study . The study hypothesis topiramate effective treatment type 2 diabetes weight reduction . During initial 8-weeks , oral dos take twice daily topiramate placebo gradually increase target dos ( either 96 milligram [ mg ] , 192mg , 256mg daily ) ; dose maintain 44 week .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Diagnosis Type 2 Diabetes , receive second generation sulfonylurea therapy ( may include : glipizide , gliclazide , glimepiride , glibenclamide/glyburide , gliquadone ) least 4 month stable dose least 2 month Body Mass Index &gt; = 27 &lt; 50 HbA1c &lt; 11 % enrollment Diagnosed hypertension hyperlipidemia must control Female patient must postmenopausal least 1 year , surgically incapable childbearing , practice acceptable method contraception ( require negative pregnancy test ) Known contraindication hypersensitivity topiramate sulfonylurea therapy Pregnancy woman nurse plan become pregnant study Diagnosed Type 1 diabetes History severe recurrent hypoglycemic episode Treatment antidiabetic agent sulfonylurea</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Obesity</keyword>
	<keyword>Type 2 Diabetes Mellitus</keyword>
	<keyword>HbA1c</keyword>
	<keyword>Sulfonylurea</keyword>
	<keyword>Topiramate</keyword>
	<keyword>Adult-Onset Diabetes Mellitus ( AODM )</keyword>
</DOC>